These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 16968824)
21. Assessment of the implementation of pharmacist prescribing: Challenges and pathways for ambulatory practice. Milani GJ; Damasceno LT; Tiguman GMB; Aguiar PM Res Social Adm Pharm; 2024 Sep; 20(9):870-879. PubMed ID: 38762366 [TBL] [Abstract][Full Text] [Related]
22. Do community pharmacists have the attitudes and knowledge to support evidence based self-management of low back pain? Silcock J; Moffett JK; Edmondson H; Waddell G; Burton AK BMC Musculoskelet Disord; 2007 Jan; 8():10. PubMed ID: 17266748 [TBL] [Abstract][Full Text] [Related]
23. How have pharmacists in different practice settings integrated prescribing privileges into practice in Alberta? A qualitative exploration. Guirguis LM; Makowsky MJ; Hughes CA; Sadowski CA; Schindel TJ; Yuksel N J Clin Pharm Ther; 2014 Aug; 39(4):390-8. PubMed ID: 24805908 [TBL] [Abstract][Full Text] [Related]
24. Supplementary nurse prescribing for patients with skin conditions: a national questionnaire survey. Carey N; Courtenay M; Burke J J Clin Nurs; 2007 Jul; 16(7):1230-7. PubMed ID: 17584340 [TBL] [Abstract][Full Text] [Related]
25. Supplementary prescribing by community and primary care pharmacists: an analysis of PACT data, 2004-2006. Guillaume L; Cooper R; Avery A; Mitchell S; Ward P; Anderson C; Bissell P; Hutchinson A; James V; Lymn J; McIntosh A; Murphy E; Ratcliffe J J Clin Pharm Ther; 2008 Feb; 33(1):11-6. PubMed ID: 18211611 [TBL] [Abstract][Full Text] [Related]
26. Analysis of community chain pharmacists' interventions on electronic prescriptions. Warholak TL; Rupp MT J Am Pharm Assoc (2003); 2009; 49(1):59-64. PubMed ID: 19196598 [TBL] [Abstract][Full Text] [Related]
27. Pharmacists' perception of pharmaceutical care in community pharmacy: a questionnaire survey in Northwest China. Fang Y; Yang S; Feng B; Ni Y; Zhang K Health Soc Care Community; 2011 Mar; 19(2):189-97. PubMed ID: 20880089 [TBL] [Abstract][Full Text] [Related]
28. Piloting the United Kingdom 'Prescribing Safety Assessment' with pharmacist prescribers in Scotland. Reid F; Power A; Stewart D; Watson A; Zlotos L; Campbell D; McIntosh T; Maxwell S Res Social Adm Pharm; 2018 Jan; 14(1):62-68. PubMed ID: 28089608 [TBL] [Abstract][Full Text] [Related]
29. Pharmaceutical care in a community-based practice setting in Jordan: where are we now with our attitudes and perceived barriers? Aburuz S; Al-Ghazawi M; Snyder A Int J Pharm Pract; 2012 Apr; 20(2):71-9. PubMed ID: 22416931 [TBL] [Abstract][Full Text] [Related]
30. Pharmacists' adoption into practice of newly reclassified medicines from diverse therapeutic areas in Scotland: a quantitative study of factors associated with decision-making. Paudyal V; Hansford D; Cunningham S; Stewart D Res Social Adm Pharm; 2014; 10(1):88-105. PubMed ID: 23665077 [TBL] [Abstract][Full Text] [Related]
31. Clinical and financial impact of pharmacy services in the intensive care unit: pharmacist and prescriber perceptions. MacLaren R; Brett McQueen R; Campbell J Pharmacotherapy; 2013 Apr; 33(4):401-10. PubMed ID: 23468188 [TBL] [Abstract][Full Text] [Related]
32. Analysis of pharmacists' interventions on electronic versus traditional prescriptions in 2 community pharmacies. Gilligan AM; Miller K; Mohney A; Montenegro C; Schwarz J; Warholak TL Res Social Adm Pharm; 2012; 8(6):523-32. PubMed ID: 22264963 [TBL] [Abstract][Full Text] [Related]
33. 'It's showed me the skills that he has': pharmacists' and mentors' views on pharmacist supplementary prescribing. Lloyd F; Parsons C; Hughes CM Int J Pharm Pract; 2010 Feb; 18(1):29-36. PubMed ID: 20405593 [TBL] [Abstract][Full Text] [Related]
34. Pharmacists' concerns and perceived benefits from the deregulation of hormonal emergency contraception (HEC). Blackwell D; Cooper N; Taylor G; Holden K Br J Fam Plann; 1999 Oct; 25(3):100-4. PubMed ID: 10567059 [TBL] [Abstract][Full Text] [Related]
35. Pharmacists' Prescribing in Saudi Arabia: Cross-Sectional Study Describing Current Practices and Future Perspectives. Ajabnoor AM; Cooper RJ Pharmacy (Basel); 2020 Sep; 8(3):. PubMed ID: 32887315 [TBL] [Abstract][Full Text] [Related]
36. Views of pharmacist prescribers, doctors and patients on pharmacist prescribing implementation. Stewart DC; George J; Bond CM; Diack HL; McCaig DJ; Cunningham S Int J Pharm Pract; 2009 Apr; 17(2):89-94. PubMed ID: 20214256 [TBL] [Abstract][Full Text] [Related]
37. [Opinions and attitudes of Flemish pharmacists and general practitioners towards INN prescribing. A survery in Antwerp and East Flanders]. Fraeyman J; De Winter J; De Loof H; Van Hal G; Beutels P; Remmen R; De Meyer GR J Pharm Belg; 2013 Jun; (2):18-31. PubMed ID: 23798183 [TBL] [Abstract][Full Text] [Related]
38. Perceived barriers to provision of medication therapy management services (MTMS) and the likelihood of a pharmacist to work in a pharmacy that provides MTMS. Blake KB; Madhavan SS Ann Pharmacother; 2010 Mar; 44(3):424-31. PubMed ID: 20179254 [TBL] [Abstract][Full Text] [Related]
39. British community pharmacists' views of physician-assisted suicide (PAS). Hanlon TR; Weiss MC; Rees J J Med Ethics; 2000 Oct; 26(5):363-9. PubMed ID: 11055040 [TBL] [Abstract][Full Text] [Related]
40. The role of perceived impact on relationship quality in pharmacists' willingness to influence indication-based off-label prescribing decisions. Basak R; Bentley JP; McCaffrey DJ; Bouldin AS; Banahan BF Soc Sci Med; 2015 May; 132():181-9. PubMed ID: 25818379 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]